Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP545086.RAlW3iYYuYA3LJkJ9xti2p-TVLxX4kPvdJdOgZLPOzRCU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP545086.RAlW3iYYuYA3LJkJ9xti2p-TVLxX4kPvdJdOgZLPOzRCU130_assertion type Assertion NP545086.RAlW3iYYuYA3LJkJ9xti2p-TVLxX4kPvdJdOgZLPOzRCU130_head.
- NP545086.RAlW3iYYuYA3LJkJ9xti2p-TVLxX4kPvdJdOgZLPOzRCU130_assertion description "[While MAL was largely unmethylated at the transcription start site (Region 1; -48 to +73 bp) in primary serous ovarian cancers, methylation of an upstream region (Region 2; -452 to -266 bp) was inversely correlated with MAL transcription in the primary cancers (R = -0.463) and ovarian cancer cell lines (R = -0.444).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545086.RAlW3iYYuYA3LJkJ9xti2p-TVLxX4kPvdJdOgZLPOzRCU130_provenance.
- NP545086.RAlW3iYYuYA3LJkJ9xti2p-TVLxX4kPvdJdOgZLPOzRCU130_assertion evidence source_evidence_literature NP545086.RAlW3iYYuYA3LJkJ9xti2p-TVLxX4kPvdJdOgZLPOzRCU130_provenance.
- NP545086.RAlW3iYYuYA3LJkJ9xti2p-TVLxX4kPvdJdOgZLPOzRCU130_assertion SIO_000772 19642140 NP545086.RAlW3iYYuYA3LJkJ9xti2p-TVLxX4kPvdJdOgZLPOzRCU130_provenance.
- NP545086.RAlW3iYYuYA3LJkJ9xti2p-TVLxX4kPvdJdOgZLPOzRCU130_assertion wasDerivedFrom befree-20150227 NP545086.RAlW3iYYuYA3LJkJ9xti2p-TVLxX4kPvdJdOgZLPOzRCU130_provenance.
- NP545086.RAlW3iYYuYA3LJkJ9xti2p-TVLxX4kPvdJdOgZLPOzRCU130_assertion wasGeneratedBy ECO_0000203 NP545086.RAlW3iYYuYA3LJkJ9xti2p-TVLxX4kPvdJdOgZLPOzRCU130_provenance.